Methylene blue—current knowledge, fluorescent properties, and its future use T Cwalinski, W Polom, L Marano, G Roviello, A D’Angelo, N Cwalina, ... Journal of clinical medicine 9 (11), 3538, 2020 | 83 | 2020 |
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer W Cytawa, AK Seitz, S Kircher, K Fukushima, J Tran-Gia, A Schirbel, ... European journal of nuclear medicine and molecular imaging 47, 168-177, 2020 | 79 | 2020 |
Usage of invisible near infrared light (NIR) fluorescence with indocyanine green (ICG) and methylene blue (MB) in urological oncology. Part 1 W Polom, M Markuszewski, YS Rho, M Matuszewski Central European journal of urology 67 (2), 142, 2014 | 48 | 2014 |
Use of invisible near infrared light fluorescence with indocyanine green and methylene blue in urology. Part 2 W Polom, M Markuszewski, YS Rho, M Matuszewski Central European journal of urology 67 (3), 310, 2014 | 33 | 2014 |
Fluorescent versus radioguided lymph node mapping in bladder cancer W Polom, M Markuszewski, W Cytawa, P Czapiewski, P Lass, ... Clinical genitourinary cancer 15 (3), e405-e409, 2017 | 29 | 2017 |
Comparison of real-time fluorescent indocyanine green and 99mTc-nanocolloid radiotracer navigation in sentinel lymph node biopsy of penile cancer M Markuszewski, W Polom, W Cytawa, P Czapiewski, P Lass, ... Clinical genitourinary cancer 13 (6), 574-580, 2015 | 26 | 2015 |
Multispectral imaging using fluorescent properties of indocyanine green and methylene blue in colorectal surgery—initial experience W Polom, M Migaczewski, J Skokowski, M Swierblewski, T Cwalinski, ... Journal of Clinical Medicine 11 (2), 368, 2022 | 17 | 2022 |
Radio-guided lymph node mapping in bladder cancer using SPECT/CT and intraoperative γ-probe methods W Polom, M Markuszewski, W Cytawa, P Lass, M Matuszewski Clinical Nuclear Medicine 41 (8), e362-e367, 2016 | 16 | 2016 |
The pharmacokinetics and hypoglycaemic effect of sunitinib in the diabetic rabbits E Szałek, A Karbownik, K Sobańska, T Grabowski, W Połom, ... Pharmacological Reports 66 (5), 892-896, 2014 | 16 | 2014 |
Influence of obesity and type 2 diabetes mellitus on the pharmacokinetics of tramadol after single oral dose administration J Porażka, E Szałek, W Połom, M Czajkowski, T Grabowski, ... European Journal of Drug Metabolism and Pharmacokinetics 44, 579-584, 2019 | 13 | 2019 |
Can the evolution of male contraception lead to a revolution? Review of the current state of knowledge M Frankiewicz, W Połom, M Matuszewski Central European Journal of Urology 71 (1), 108, 2018 | 13 | 2018 |
Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens W Cytawa, S Kircher, H Kübler, RA Werner, S Weber, P Hartrampf, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (11), 3938-3949, 2022 | 12 | 2022 |
The influence of the time-of-day administration of the drug on the pharmacokinetics of sunitinib in rabbits E Szałek, A Wolc, A Karbownik, K Sobańska, W Połom, T Grabowski, ... | 12 | 2014 |
Sunitinib in combination with clarithromycin or azithromycin–is there a risk of interaction or not? E Szałek, A Karbownik, W Połom, M Matuszewski, K Sobańska, H Urjasz, ... Pharmacological Reports 64 (6), 1554-1559, 2012 | 11 | 2012 |
Laparoscopic nephroureterectomy with transvesical single-port distal ureter and bladder cuff dissection: points of technique and initial surgical outcomes with five patients M Roslan, M Markuszewski, J Kłącz, M Sieczkowski, W Połom, ... Videosurgery and Other Miniinvasive Techniques 9 (2), 267-272, 2014 | 10 | 2014 |
Overactive bladder treatment: application of methylene blue to improve the injection technique of onabotulinum toxin A M Szczypior, W Połom, M Markuszewski, K Ciura, M Buszewska-Forajta, ... Scandinavian journal of urology 51 (6), 474-478, 2017 | 9 | 2017 |
Tetraspanin CD151 mediates communication between prostate cancer cells and osteoblasts A Grudowska, D Czaplińska, W Połom, M Matuszewski, R Sądej, ... Acta Biochimica Polonica 64 (1), 135-141, 2017 | 9 | 2017 |
The effect of sunitinib on the plasma exposure of intravenous paracetamol and its major metabolite: paracetamol glucuronide A Karbownik, E Szałek, K Sobańska, W Połom, T Grabowski, ... European journal of drug metabolism and pharmacokinetics 40, 163-170, 2015 | 9 | 2015 |
Cukrzyca ciążowa—narastający problem diagnostyczny i epidemiologiczny K Kopacz, M Myśliwiec, I Techmańska, A Brandt, B Wolnik, K Preis, ... Diabetologia Kliniczna 12 (3), 96-102, 2011 | 9 | 2011 |
Rekonstrukcja gruczołu piersiowego u chorych leczonych z powodu raka piersi. Przegląd piśmiennictwa K Połom, D Murawa, J Wasiewicz, W Połom, P Murawa Współczesna Onkologia 6 (13), 304-308, 2009 | 9* | 2009 |